When we refer to “developed sales” of a product, we mean our consolidated net sales minus sales of products to our alliance partners plus non-consolidated sales made through our alliances with Bristol-Myers Squibb on Plavix®/ Iscover® (clopidogrel) and Aprovel®/Avapro®/ Karvea® (irbesartan) and Fujisawa on Stilnox®/Myslee® (zolpidem). Our alliance partners provide us with information regarding their sales in order to allow us to calculate developed sales.
Developed sales are a useful measurement tool because they demonstrate trends in the overall presence of our products in the market.